CME/ABIM MOC–Certified On-Demand Webcast

Share

Program Content

Activities

  • Biomarkers in Lung Cancer
    The New Biomarkers Clinicians Need to Know for Precision Therapy in Lung Cancer
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 30, 2020

    Expires: November 29, 2021

Provided by

ProCE Banner

Supporters

Daiichi Sankyo, Inc.

Merck Sharp & Dohme Corp.